<div class="container">

<table style="width: 100%;"><tr>
<td>hiscr</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Calculates HiSCR scores given a percentage parameter.</h2>

<h3>Description</h3>

<p>Calculates HiSCR scores given a percentage parameter.
</p>


<h3>Usage</h3>

<pre><code class="language-R">hiscr(
  baseline_abscess,
  baseline_nodule,
  baseline_fistula,
  timepoint_abscess,
  timepoint_nodule,
  timepoint_fistula,
  percentage
)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>baseline_abscess</code></td>
<td>
<p>Integer vector representing the abscess count at
baseline.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>baseline_nodule</code></td>
<td>
<p>Integer vector representing the inflammatory nodule
count at baseline.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>baseline_fistula</code></td>
<td>
<p>Integer vector representing the draining fistula
count at baseline.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>timepoint_abscess</code></td>
<td>
<p>Integer vector representing the abscess count at the
time point of interest.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>timepoint_nodule</code></td>
<td>
<p>Integer vector representing the inflammatory nodule
count at the time point of interest.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>timepoint_fistula</code></td>
<td>
<p>Integer vector representing the draining fistula
count at the time point of interest.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>percentage</code></td>
<td>
<p>Numeric value specifying the percentage required for HiSCR
(e.g., 50 for HiSCR50, 75 for HiSCR75, etc.).</p>
</td>
</tr>
</table>
<h3>Value</h3>

<p>A logical vector indicating whether the HiSCR response is achieved
for each set of input parameters.
</p>


<h3>References</h3>

<p>Kimball, A B et al. “HiSCR (Hidradenitis Suppurativa Clinical
Response): a novel clinical endpoint to evaluate therapeutic outcomes in
patients with hidradenitis suppurativa from the placebo-controlled portion
of a phase 2 adalimumab study.” Journal of the European Academy of
Dermatology and Venereology : JEADV vol. 30,6 (2016): 989-94.
doi:10.1111/jdv.13216
</p>


<h3>Examples</h3>

<pre><code class="language-R">hiscr(
  baseline_abscess = c(3, 2, 4),
  baseline_nodule = c(5, 4, 6),
  baseline_fistula = c(2, 1, 3),
  timepoint_abscess = c(1, 1, 2),
  timepoint_nodule = c(2, 3, 2),
  timepoint_fistula = c(2, 1, 3),
  percentage = 50
)
</code></pre>


</div>